Our previous proteomics study showed that VLCAD, the initial rate-limiting enzyme in mitochondrial fatty acid β-oxidation, was decreased in the LAA tissue of permanent AF patients [15]. This evidence concerns the gene ACADVL and atrial fibrillation.